Global Acute Myeloid Leukemia Market and Competitive Landscape - 2018

  • ID: 4630035
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest research Global Acute Myeloid Leukemia Market and Competitive Landscape - 2018, provides comprehensive insights into Acute Myeloid Leukemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Acute Myeloid Leukemia market size and drug sales. This research also provides insights into Acute Myeloid Leukemia epidemiology and late stage pipeline.

The research is classified into following sections - Acute Myeloid Leukemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Acute Myeloid Leukemia pipeline insights covering late stage clinical trials pipeline; Acute Myeloid Leukemia prevalence trends by countries; Acute Myeloid Leukemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:
  • Acute Myeloid Leukemia pipeline: Find out the drugs in clinical trials for Acute Myeloid Leukemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Acute Myeloid Leukemia epidemiology: Find out the prevalence of Acute Myeloid Leukemia by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Acute Myeloid Leukemia products: Identify key products marketed and prescribed for Acute Myeloid Leukemia by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Acute Myeloid Leukemia market size: Find out the market size for Acute Myeloid Leukemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Acute Myeloid Leukemia drug sales: Find out the sales of Acute Myeloid Leukemia drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Acute Myeloid Leukemia drugs sales forecast: Sales forecast for Acute Myeloid Leukemia drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Acute Myeloid Leukemia market share analysis: Find out the market shares of Acute Myeloid Leukemia drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research:
  • Evaluate commercial market opportunities for Acute Myeloid Leukemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Acute Myeloid Leukemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Acute Myeloid Leukemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Acute Myeloid Leukemia: Disease Overview
1.1. Acute Myeloid Leukemia Symptoms
1.2. Acute Myeloid Leukemia Etiology
1.3. Acute Myeloid Leukemia Diagnosis
1.4. Acute Myeloid Leukemia Treatment Options

2. Acute Myeloid Leukemia Pipeline Insights
2.1. Acute Myeloid Leukemia Phase 3 Clinical Trials
2.2. Acute Myeloid Leukemia Phase 2 Clinical Trials
2.3. Acute Myeloid Leukemia Phase 1 Clinical Trials

3. Acute Myeloid Leukemia Epidemiology Analysis

4. US Acute Myeloid Leukemia Market Insights
4.1. Marketed Products for Acute Myeloid Leukemia in US
4.2. US Acute Myeloid Leukemia Market Size & Forecast
4.3. US Acute Myeloid Leukemia Product Sales Forecast
4.4. US Acute Myeloid Leukemia Market Share Analysis

5. Germany Acute Myeloid Leukemia Market Insights
5.1. Marketed Products for Acute Myeloid Leukemia in Germany
5.2. Germany Acute Myeloid Leukemia Market Size & Forecast
5.3. Germany Acute Myeloid Leukemia Product Sales Forecast
5.4. Germany Acute Myeloid Leukemia Market Share Analysis

6. France Acute Myeloid Leukemia Market Insights
6.1. Marketed Products for Acute Myeloid Leukemia in France
6.2. France Acute Myeloid Leukemia Market Size & Forecast
6.3. France Acute Myeloid Leukemia Product Sales Forecast
6.4. France Acute Myeloid Leukemia Market Share Analysis

7. Italy Acute Myeloid Leukemia Market Insights
7.1. Marketed Products for Acute Myeloid Leukemia in Italy
7.2. Italy Acute Myeloid Leukemia Market Size & Forecast
7.3. Italy Acute Myeloid Leukemia Product Sales Forecast
7.4. Italy Acute Myeloid Leukemia Market Share Analysis

8. Spain Acute Myeloid Leukemia Market Insights
8.1. Marketed Products for Acute Myeloid Leukemia in Spain
8.2. Spain Acute Myeloid Leukemia Market Size & Forecast
8.3. Spain Acute Myeloid Leukemia Product Sales Forecast
8.4. Spain Acute Myeloid Leukemia Market Share Analysis

9. UK Acute Myeloid Leukemia Market Insights
9.1. Marketed Products for Acute Myeloid Leukemia in UK
9.2. UK Acute Myeloid Leukemia Market Size & Forecast
9.3. UK Acute Myeloid Leukemia Product Sales Forecast
9.4. UK Acute Myeloid Leukemia Market Share Analysis

10. Europe Acute Myeloid Leukemia Market Insights
10.1. Europe Acute Myeloid Leukemia Market Size & Forecast
10.2. Europe Acute Myeloid Leukemia Product Sales Forecast
10.3. Europe Acute Myeloid Leukemia Market Share Analysis

11. Japan Acute Myeloid Leukemia Market Insights
11.1. Marketed Products for Acute Myeloid Leukemia in Japan
11.2. Japan Acute Myeloid Leukemia Market Size & Forecast
11.3. Japan Acute Myeloid Leukemia Product Sales Forecast
11.4. Japan Acute Myeloid Leukemia Market Share Analysis

12. Global Acute Myeloid Leukemia Market Insights
12.1. Global Acute Myeloid Leukemia Market Size & Forecast
12.2. Global Acute Myeloid Leukemia Product Sales Forecast
12.3. Global Acute Myeloid Leukemia Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Acute Myeloid Leukemia Phase 3 Clinical Trials, Global, 2018
Table 2: Acute Myeloid Leukemia Phase 2 Clinical Trials, Global, 2018
Table 3: Acute Myeloid Leukemia Phase 1 Clinical Trials, Global, 2018
Table 4: Acute Myeloid Leukemia Prevalence by G7 Countries, 2017 - 2023
Table 5: Marketed Products for Acute Myeloid Leukemia in US, 2017
Table 6: US Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 7: US Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 8: US Acute Myeloid Leukemia Market Trends, 2014 - 2023
Table 9: Marketed Products for Acute Myeloid Leukemia in Germany, 2017
Table 10: Germany Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 11: Germany Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 12: Germany Acute Myeloid Leukemia Market Trends, 2014 - 2023
Table 13: Marketed Products for Acute Myeloid Leukemia in France, 2017
Table 14: France Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 15: France Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 16: France Acute Myeloid Leukemia Market Trends, 2014 - 2023
Table 17: Marketed Products for Acute Myeloid Leukemia in Italy, 2017
Table 18: Italy Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 19: Italy Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 20: Italy Acute Myeloid Leukemia Market Trends, 2014 - 2023
Table 21: Marketed Products for Acute Myeloid Leukemia in Spain, 2017
Table 22: Spain Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 23: Spain Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 24: Spain Acute Myeloid Leukemia Market Trends, 2014 - 2023
Table 25: Marketed Products for Acute Myeloid Leukemia in UK, 2017
Table 26: UK Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 27: UK Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 28: UK Acute Myeloid Leukemia Market Trends, 2014 - 2023
Table 29: Europe Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 30: Europe Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 31: Marketed Products for Acute Myeloid Leukemia in Japan, 2017
Table 32: Japan Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 33: Japan Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Table 34: Japan Acute Myeloid Leukemia Market Trends, 2014 - 2023
Table 35: Global Acute Myeloid Leukemia Market Size & Forecast ($mn), 2014 - 2023
Table 36: Global Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023

List of Figures
Figure 1: Acute Myeloid Leukemia Pipeline by Phase (%), Global, 2018
Figure 2: Acute Myeloid Leukemia Prevalence by G7 Countries, 2017 - 2023
Figure 3: US Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 4: US Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 5: US Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 6: US Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 7: Germany Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 8: Germany Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 9: Germany Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 10: Germany Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 11: France Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 12: France Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 13: France Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 14: France Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 15: Italy Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 16: Italy Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 17: Italy Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 18: Italy Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 19: Spain Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 20: Spain Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 21: Spain Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 22: Spain Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 23: UK Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 24: UK Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 25: UK Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 26: UK Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 27: Europe Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 28: Europe Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 29: Europe Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 30: Europe Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 31: Japan Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 32: Japan Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 33: Japan Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 34: Japan Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Figure 35: Global Acute Myeloid Leukemia Market Size ($mn), 2014 - 2023
Figure 36: Global Acute Myeloid Leukemia Product Sales ($mn), 2014 - 2023
Figure 37: Global Acute Myeloid Leukemia Market Share by Products (%), 2017
Figure 38: Global Acute Myeloid Leukemia Market - Future Market Share (%), 2023
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll